Observational Study of Persons With Hepatitis B Virus Infection in North America
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background:
- Chronic hepatitis B virus infection is a leading cause of morbidity and mortality from end stage liver disease and liver cancer. Although significant progress has been made recently in hepatitis B therapy, current knowledge about how to manage the infection is limited because most treatment trials involve 1 to 2 years of therapy at most, even though most patients require treatment of much longer duration for optimal long-term outcome. To improve current knowledge on the disease and long-term disease progression, the Hepatitis B Research Network is collecting health and disease information from individuals who have been diagnosed with hepatitis B.
Objectives:
- To study individuals with hepatitis B and identify factors that affect the way the disease progresses.
Eligibility:
- Individuals at least 18 years of age who have been diagnosed with hepatitis B.
Design:
- Participants will be screened with a physical examination and medical history. Health information will be collected through questionnaires and surveys on health behaviors, and family history of liver disease. Participants will also provide blood samples, and those who have had a liver biopsy within the past 2 years or have one during the course of the study will provide biopsy material for further study.
- Information will be collected during a series of study visits. Each visit will take approximately 1 hour. During the first year, participants will have study visits 12 weeks, 24 weeks, and 48 weeks after entering the study. In subsequent years, participants will have a study visit approximately every 24 weeks (6 months) until the end of the study.
- Additional visits will be required of women who are pregnant when enrolled in the study or become pregnant during the course of the study.
- Participants whose hepatitis B status changes during the course of the study (for example, a flare of disease activity) may be asked to return for more frequent visits.
| Condition |
|---|
|
Chronic Hepatitis B e Antigen Positive Chronic Hepatitis B e Antigen Negative |
| Study Type: | Observational |
| Official Title: | Observational Study of Persons With Hepatitis B Virus Infection in North America (Cohort Study) |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
- INCLUSION CRITERIA:
- Written informed consent
- At least 18 years of age
- HBsAg-positive and either
- Pregnant
- Anti-HDV positive
- Diagnosed with acute HBV infection or experiencing a hepatitis flare
- Immune tolerant or immune active phenotype
- Potentially eligible for the Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B ancillary study.
EXCLUSION CRITERIA:
- History of hepatic decompensation
- Hepatocellular carcinoma (HCC)
- History of solid organ transplantation or bone marrow transplantation
- Chronic immunosuppression therapy
- Current hepatitis B antiviral treatment (except pregnant women and patients who are anti-HDV positive)
- Known HIV co-infection (patients with HDV or HCV co-infection are not excluded).
- Medical or social condition which, in the opinion of the investigator, would make the patient unsuitable for the study or interfere with or prevent follow-up per protocol
- Unable or unwilling to return for follow-up visits
Contacts and Locations| Contact: Elenita Rivera, R.N. | (301) 496-3531 | erivera@cc.nih.gov |
| Contact: Marc G Ghany, M.D. | (301) 402-5115 | mg228m@nih.gov |
| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
| Bethesda, Maryland, United States, 20892 | |
| Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov | |
| Principal Investigator: | Marc G Ghany, M.D. | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
More Information
Additional Information:
Publications:
| ClinicalTrials.gov Identifier: | NCT01306071 History of Changes |
| Other Study ID Numbers: | 110108, 11-DK-0108 |
| Study First Received: | February 26, 2011 |
| Last Updated: | May 1, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Cirrhosis Natural History Hepatitis B |
Additional relevant MeSH terms:
|
Hepatitis Hepatitis A Hepatitis B Hepatitis, Chronic Virus Diseases Hepatitis B, Chronic Liver Diseases |
Digestive System Diseases Hepatitis, Viral, Human Enterovirus Infections Picornaviridae Infections RNA Virus Infections Hepadnaviridae Infections DNA Virus Infections |
ClinicalTrials.gov processed this record on June 17, 2013